This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Mitsubishi Tanabe Pharma Corporation, Niigata University. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 263 
2 out of 73 
Years Active: 2021-2023
Title: Tohru Minamino: Innovator in Senescent Cell Elimination
Introduction
Tohru Minamino is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of senescent cell elimination. With a total of 2 patents to his name, Minamino's work is paving the way for innovative treatments in age-related diseases.
Latest Patents
Minamino's latest patents focus on agents for eliminating senescent cells. The first patent presents an agent or pharmaceutical composition that includes an SGLT2 inhibitor, aimed at effectively targeting and eliminating these cells. The second patent reiterates this innovative approach, emphasizing the potential of SGLT2 inhibitors in promoting healthier aging.
Career Highlights
Throughout his career, Tohru Minamino has worked with prominent organizations, including Mitsubishi Tanabe Pharma Corporation and Niigata University. His experience in these institutions has allowed him to develop and refine his groundbreaking ideas in the pharmaceutical industry.
Conclusion
Tohru Minamino's contributions to the field of senescent cell elimination highlight his role as an influential inventor. His innovative patents and career achievements reflect his commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile